Clinical significance of TC21 overexpression in oral cancer

Journal of Oral Pathology and Medicine

Volumn 39, Issue 6, 2010, Pages 477-485

  MacHa, Muzafar A ^a   Matta, Ajay ^a   Sriram, Uma ^a   Thakkar, Alok ^a   Shukla, N K ^b   Datta Gupta, Siddhartha ^a   Ralhan, Ranju ^a,c,d  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b INSTITUTE ROTARY CANCER HOSPITAL   (India)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

dysplasia; leukoplakia; oral squamous cell carcinoma; R Ras2; TC21

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; MITOGEN ACTIVATED PROTEIN KINASE 1; MOLECULAR MARKER; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN 14 3 3; PROTEIN TC21; UNCLASSIFIED DRUG; EXONUCLEASE; EXORIBONUCLEASE; MAPK1 PROTEIN, HUMAN; MEMBRANE PROTEIN; MONOMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; RRAS2 PROTEIN, HUMAN; SFN PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER CELL; CANCER SURGERY; CANCER TISSUE; CLINICAL TRIAL; DIFFERENTIAL DISPLAY; DYSPLASIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MOUTH CANCER; MOUTH CARCINOMA; PATHOLOGY; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEIVER OPERATING CHARACTERISTIC; SQUAMOUS CELL CARCINOMA; BIOSYNTHESIS; CELL NUCLEUS; DISEASE FREE SURVIVAL; GENE EXPRESSION; GENETICS; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MOUTH TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE; UPREGULATION;

14-3-3 PROTEINS; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL NUCLEUS; DISEASE-FREE SURVIVAL; EXONUCLEASES; EXORIBONUCLEASES; GENE EXPRESSION; HUMANS; IMMUNOPRECIPITATION; KAPLAN-MEIER ESTIMATE; LEUKOPLAKIA, ORAL; MEMBRANE PROTEINS; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MONOMERIC GTP-BINDING PROTEINS; MOUTH NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; ROC CURVE; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77954356261     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00854.x     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008 58 : 71 96.
2. Hunter DK, Parkinson KE, Harrison RP. Profiling early head and neck cancer. Nat Rev Cancer 2005 5 : 127 135.
3. Warnakulasuriya AK, Ralhan R. Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco - a review. J Oral Pathol Med 2007 36 : 63 77.
4. Arora S, Matta A, Shukla NK, et al. Identification of differentially expressed genes in oral squamous cell carcinoma. Mol Carcinogenesis 2005 42 : 97 108.
5. Ehrhardt A, Ehrhardt RG, Guo X, Schrader WJ. Ras and relatives-job sharing and networking keep an old family together. Exp Hematol 2002 30 : 1089 1106.
6. Bos LJ. Ras-like GTPases. Biochim Biophys Acta 1997 1333 : 19 31.
7. Downward J. Ras signalling and apoptosis. Curr Opin Genet Dev 1998 8 : 49 54.
8. Campbell LS, Khosravi-Far R, Rossman LK, Clark JG, Der JC. Increasing complexity of Ras signaling. Oncogene 1998 17 : 1395 1413.
9. Lowy RD, Willumsen MB. Function and regulation of ras. Annu Rev Biochem 1993 62 : 851 891.
10. Chang HC, Karim FD, O'Neill EM, et al. Ras signal transduction pathway in Drosophila eye development. Cold Spring Harb Symp Quant Biol 1994 59 : 147 153.
11. Huang LA, Ostrowski CM, Berard D, et al. Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus. Cell 1981 27 : 245 255.
12. Graham MS, Vojtek BA, Huff YS, et al. TC21 causes transformation by Raf-independent signaling pathways. Mol Cell Biol 1996 16 : 6132 6140.
13. Clark JG, Kinch SM, Gilmer MT, et al. Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers. Oncogene 1996 12 : 169 176.
14. Rosario M, Paterson FH, Marshall JC. Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells. EMBO J 1999 18 : 1270 1279.
15. Erdogan M, Pozzi A, Bhowmick N, et al. Transforming growth factor-beta (TGF-beta) and TGF-beta-associated kinase 1 are required for R-Ras-mediated transformation of mammary epithelial cells. Cancer Res 2008 68 : 6224 6231.
16. Matta A, DeSouza VL, Shukla KN, et al. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry. J Proteome Res 2008 72 : 2078 2087.
17. Sharma R, Sud N, Chattopadhyay KT, et al. TC21/R-Ras2 upregulation in esophageal tumorigenesis: potential diagnostic implications. Oncology 2005 69 : 10 18.
18. Sawhney M, Matta A, Macha AM, et al. Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients. Int J Cancer 2009 124 : 2098 2105.
19. Zhu Y, Zhong X, Zheng S, et al. Transformation of immortalized colorectal crypt cells by microcystin involving constitutive activation of Akt and MAPK cascade. Carcinogenesis 2005 26 : 1207 1214.
20. Graham MS, Cox DA, Drivas G, et al. Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation. Mol Cell Biol 1994 14 : 4108 4115.
21. Lopez-Barahona M, Bustelo RX, Barbacid M. The TC21 oncoprotein interacts with the Ral guanosine nucleotide dissociation factor. Oncogene 1996 12 : 463 470.
22. Marshall JC. Cell signalling, Raf gets it together. Nature 1996 383 : 127 128.
23. Graham MS, Oldham MS, Martin BC, et al. TC21 and Ras share indistinguishable transforming and differentiating activities. Oncogene 1999 18 : 2107 2116.
24. Carboni MJ, Yan N, Cox DA, et al. Farnesyl-transferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation. Oncogene 1995 10 : 1905 1913.
25. Keely PJ, Rusyn EV, Cox AD, Parise LV. R-Ras signals through specific integrin alpha cytoplasmic domains to promote migration and invasion of breast epithelial cells. J Cell Biol 1999 145 : 1077 1088.
26. Rong R, He Q, Liu Y, et al. TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-kappaB signaling pathway. Oncogene 2002 21 : 1062 1070.
27. Muslin AJ, Xing H. 14-3-3 proteins: regulation of subcellular localization by molecular interference. Cell Signal 2000 12 : 703 709.
28. Morrison DK. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 2009 19 : 16 23.
29. Seimiya H, Sawada H, Muramatsu Y, et al. Involvement of 14-3-3 proteins in nuclear localization of telomerase. EMBO J 2000 19 : 2652 2661.
30. Ranganathan A, Yazicioglu MN, Cobb MH. The nuclear localization of ERK2 occurs by mechanisms both independent of and dependent on energy. J Biol Chem 2006 281 : 15645 15652.
31. Ye K, Hurt KJ, Wu FY, et al. Pike. A nuclear gtpase that enhances PI3kinase activity and is regulated by protein 4.1N. Cell 2000 103 : 919 930.
32. Jee YA, Rong R, Liu X, et al. PIKE/nuclear PI 3-kinase signaling mediates the antiapoptotic actions of NGF in the nucleus. EMBO J 2004 23 : 3995 4006.
33. Martelli MA, Capitani S, Neri ML. The generation of lipid signaling molecules in the nucleus. Prog Lipid Res 1999 38 : 273 308.
34. Cocco L, Maraldi MN, Capitani S, et al. Nuclear localization and signalling activity of inositol lipids. Ital J Anat Embryol 2001 106 : 31 43.